Search Results for "establish"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for establish. Results 281 to 290 of 654 total matches.

Spironolactone for Heart Failure

   
The Medical Letter on Drugs and Therapeutics • Sep 10, 1999  (Issue 1061)
heart failure because the safety and effectiveness of the drug have not been established ...
Spironolactone, an aldosterone receptor antagonist, has been FDA-approved for many years for treatment of edema, hypertension and primary hyperaldosteronism. Recently, it was reported to improve morbidity and mortality in patients with severe heart failure.
Med Lett Drugs Ther. 1999 Sep 10;41(1061):81-2 |  Show IntroductionHide Introduction

Entacapone for Parkinson's Disease

   
The Medical Letter on Drugs and Therapeutics • Jan 24, 2000  (Issue 1070)
have been reported in patients who were taking entacapone, but cause and effect have not been established ...
Entacapone (Comtan), a catechol-O-methyltransferase (COMT) inhibitor, has been approved by the FDA for adjunctive use with levodopa/carbidopa in patients with Parkinson's disease who have end-of-dose "wearing off"symptoms.
Med Lett Drugs Ther. 2000 Jan 24;42(1070):7-8 |  Show IntroductionHide Introduction

Update on Glucosamine For Osteoarthritis

   
The Medical Letter on Drugs and Therapeutics • Dec 10, 2001  (Issue 1120)
-established drugs such as acetaminophen, traditional NSAIDs or selective COX-2 inhibitors remains ...
Since the last Medical Letter article on glucosamine for osteoarthritis (vol.39, page 91, September 26, 1997), more data have become available. Glucosamine is available in US pharmacies and health food stores as sulfate, hydrochloride or n-acetyl salt.
Med Lett Drugs Ther. 2001 Dec 10;43(1120):111-2 |  Show IntroductionHide Introduction

Dexmethylphenidate (Focalin) For ADHD

   
The Medical Letter on Drugs and Therapeutics • May 13, 2002  (Issue 1130)
of methylphenidate (Ritalin, and others). Older drugs with better established dosages and longer safety records ...
Dexmethylphenidate (Focalin - Novartis), a new formulation of methylphenidate (Ritalin, and others) is now available for treatment of attention deficit/hyperactivity disorder (ADHD). Dexmethylphenidate is the d-threo-enantiomer of racemic methylphenidate. "Now the right half may be all your patients need," said a recent ad. Focalin is the third new methylphenidate formulation marketed in the last two years.
Med Lett Drugs Ther. 2002 May 13;44(1130):45-6 |  Show IntroductionHide Introduction

Beta Interferons for Multiple Sclerosis

   
The Medical Letter on Drugs and Therapeutics • Oct 14, 2002  (Issue 1141)
of the disease remains to be established (GPA Rice et al, Cochrane Database Syst Rev 2001; 4:CD002002). THREE ...
Three beta interferons are widely used in the treatment of patients with relapsing-remitting multiple sclerosis (RRMS).
Med Lett Drugs Ther. 2002 Oct 14;44(1141):88-9 |  Show IntroductionHide Introduction

Addendum: Warfarin-Acetaminophen Interaction

   
The Medical Letter on Drugs and Therapeutics • Jun 16, 2008  (Issue 1288)
. The mechanism of this interaction has not been established, but may be related to an acetaminophen metabolite ...
A reader expressed disappointment that our recent listing of “Some Warfarin Drug Interactions”1 did not include acetaminophen. Perhaps it should have. Acetaminophen can increase the anticoagulant effect of warfarin, particularly with continued use, but it does so inconsistently. The mechanism of this interaction has not been established, but may be related to an acetaminophen metabolite inhibiting vitamin K-epoxide reductase, the target for warfarin’s anticoagulant effect.2Patient susceptibility varies, possibly on a genetic basis; occasional use of acetaminophen generally has little or...
Med Lett Drugs Ther. 2008 Jun 16;50(1288):45 |  Show IntroductionHide Introduction

In Brief: Melamine

   
The Medical Letter on Drugs and Therapeutics • Oct 20, 2008  (Issue 1297)
nitrogen. Melamine itself is relatively nontoxic; the FDA has established, based on an extrapolation ...
Melamine present in infant formula and other milk products has been associated with widespread illness and some deaths among infants in China. It was also identified in pet food sold in North America after a large number of pets became ill and some died. In both the infants and the pets, renal injury appeared to be the cause.1Melamine (C3H6N6) is a heterocyclic compound, two-thirds nitrogen by weight, that is slightly soluble in water. When combined with formaldehyde, it forms melamine resin, which has a wide variety of industrial applications including the manufacturing of kitchenware,...
Med Lett Drugs Ther. 2008 Oct 20;50(1297):81 |  Show IntroductionHide Introduction

A Fixed-Dose Combination of Ibuprofen and Famotidine (Duexis)

   
The Medical Letter on Drugs and Therapeutics • Oct 31, 2011  (Issue 1376)
remains to be established. The high dose of ibuprofen in Duexis may be more than many patients need. o ...
The FDA has approved Duexis (Horizon), a fixed-dose combination of the nonsteroidal anti-inflammatory drug (NSAID) ibuprofen and the H2-receptor antagonist (H2RA) famotidine, for symptomatic relief of osteoarthritis and rheumatoid arthritis and to decrease the risk of developing gastric and duodenal ulcers in patients at risk for NSAID-associated ulcers. Vimovo, a combination of the NSAID naproxen and the proton pump inhibitor (PPI) esomeprazole, is also approved by the FDA for prevention of NSAID-associated gastric ulcers.
Med Lett Drugs Ther. 2011 Oct 31;53(1376):85-6 |  Show IntroductionHide Introduction

PDE5 Inhibitors for Erectile Dysfunction

   
The Medical Letter on Drugs and Therapeutics • Feb 06, 2012  (Issue 1383)
or dizziness, has been reported, but a cause-and-effect relationship has not been established. Visual effects ...
Sildenafil (Viagra), tadalafil (Cialis) and vardenafil (Levitra, Staxyn) have become the standard treatment for erectile dysfunction. Head-to-head comparisons of these agents are still lacking, but some differences between them and new recommendations for their dosing (see Table 2) are worth noting.
Med Lett Drugs Ther. 2012 Feb 6;54(1383):10-1 |  Show IntroductionHide Introduction

Fish Oil Supplements

   
The Medical Letter on Drugs and Therapeutics • Oct 15, 2012  (Issue 1401)
has not been established. 84 The Medical Letter • Volume 54 • Issue 1401 • October 15, 2012 CONCLUSION — Omega-3 ...
The FDA has approved 2 products containing omega-3 polyunsaturated fatty acids (PUFAs) for treatment of patients with severe hypertriglyceridemia (>500 mg/dL). Lovaza (formerly Omacor) is available by prescription. The second FDA-approved omega-3 product, Vascepa, which contains only EPA, will not be available until 2013. Many other brands of fish oil capsules are sold over the counter (OTC) as dietary supplements; the US Pharmacopeia has verified that some of these contain their labeled content, are soluble in the body, and contain neither heavy metals...
Med Lett Drugs Ther. 2012 Oct 15;54(1401):83-4 |  Show IntroductionHide Introduction